Index of reports
> Cases with Hyperlipidaemia (6)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zerit (Stavudine) where reactions include hyperlipidaemia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Zerit side effects in male
Reported by a physician from Japan on 2012-08-02
Patient: male
Reactions: Hyperlipidaemia, Oesophageal Candidiasis, Syphilis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kaletra
Dosage: 4 dosage forms daily
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-27
Truvada
Start date: 2011-08-08
Kaletra
Dosage: 6 dosage form
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-01
End date: 2006-11-26
Zerit
Dosage: 60 mg daily
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-01
End date: 2008-01-01
Zerit
Dosage: 60 mg daily
Administration route: Oral
Start date: 2009-04-29
End date: 2011-08-07
Truvada
Dosage: 1 dosage form daily
Administration route: Oral
Indication: HIV Infection
Start date: 2009-04-29
Other drugs received by patient: Tenofovir Disoproxil Fumarate; Lamivudine; Lamivudine; Tenofovir Disoproxil Fumarate
Possible Zerit side effects in male
Reported by a consumer/non-health professional from Germany on 2012-06-01
Patient: male
Reactions: Hyperlipidaemia, Virologic Failure, Diarrhoea, Anal Cancer, Lipodystrophy Acquired, Polyneuropathy
Drug(s) suspected as cause:
Cisplatin
Fluorouracil
Videx
Indication: HIV Infection
Sustiva
Indication: HIV Infection
Nelfinavir Mesylate
Indication: HIV Infection
Lamivudine
Indication: HIV Infection
Zerit
Indication: HIV Infection
Possible Zerit side effects in male
Reported by a physician from Germany on 2012-05-15
Patient: male
Reactions: Hyperlipidaemia, Virologic Failure, Diarrhoea, Anal Cancer, Lipodystrophy Acquired, Polyneuropathy
Drug(s) suspected as cause:
Zerit
Indication: HIV Infection
Videx
Indication: HIV Infection
Sustiva
Indication: HIV Infection
Cisplatin
Nelfinavir Mesylate
Indication: HIV Infection
Fluorouracil
Lamivudine (Epivir Hbv)
Indication: HIV Infection
Possible Zerit side effects in
Reported by a physician from Germany on 2012-05-09
Patient:
Reactions: Hyperlipidaemia, Drug Resistance, Diarrhoea, Anal Cancer, Lipodystrophy Acquired, Polyneuropathy
Drug(s) suspected as cause:
Lamivudine (Epivir Hbv)
Indication: HIV Infection
Sustiva
Indication: HIV Infection
Cisplatin
Zerit
Indication: HIV Infection
Videx
Indication: HIV Infection
Nelfinavir Mesylate
Indication: HIV Infection
Fluorouracil
Possible Zerit side effects in 41 year old male
Reported by a physician from Japan on 2012-03-28
Patient: 41 year old male
Reactions: Pancreatitis Acute, Death, Hyperlipidaemia, Hyperlactacidaemia, Amylase Increased, Neuropathy Peripheral, Diarrhoea, Lactic Acidosis, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Fosamprenavir Calcium
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-04
Combivir
Administration route: Oral
Indication: HIV Infection
Start date: 2001-02-13
End date: 2001-05-10
Epivir
Dosage: therapy interrupted on 09-jan-2000, discontinued on 06-jul-2001.
Administration route: Oral
Start date: 1996-10-01
End date: 2001-07-06
Saquinavir Mesylate
Indication: HIV Infection
Start date: 2001-01-05
End date: 2001-03-08
Ziagen
Dosage: therapy interrupted from 08-dec-2000 to 05-jun-2001
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2000-01-24
End date: 2001-07-06
Somatropin
Indication: Weight Decreased
Start date: 2001-03-19
End date: 2001-11-12
Raltegravir
Indication: Acquired Immunodeficiency Syndrome
Start date: 2008-09-26
Zerit
Dosage: ongoing 01-aug-1995 to 01-mar-1996 and 01-apr-1998 to 08-dec-2000.
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1995-08-01
End date: 2000-12-08
Efavirenz
Dosage: therapy interp 12/8/00,restarted 3/9/01,interrupt7/01,+restarted 7/23/01-25sep8(2622 days)
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2000-01-10
End date: 2008-09-25
Prezista
Dosage: tabs
Administration route: Oral
Indication: HIV Infection
Start date: 2008-09-26
Videx
Dosage: ongoing 01/sept/1993 - 01/aug/1994; 01/mar/1996 - 01/oct/1996; and 10/jan/2000 - 08/dec/2000
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1993-09-01
End date: 2000-12-08
Truvada
Dosage: 1 df = 1 tablet
Administration route: Oral
Indication: HIV Infection
Start date: 2008-09-26
End date: 2009-10-01
Kaletra
Dosage: 8 caps 9mar-6jul01, restarted 23jul01 stopped 4oct6 reduced to 6 tabs from 05oct6-15sep8 (1900 days)
Indication: HIV Infection
Start date: 2001-03-09
End date: 2008-09-25
Norvir
Dosage: 05jan01 to 04feb01, 05feb01 to 08mar01 and 26sep08 to ongoing.
Indication: HIV Infection
Start date: 2001-01-05
Amprenavir
Administration route: Oral
Indication: HIV Infection
Start date: 2001-07-23
End date: 2005-08-03
Other drugs received by patient: Retrovir; Viracept; Recombinate; Loperamide HCL; Crixivan; Octocog Alpha; Loperamide HCL; OIF
Possible Zerit side effects in 41 year old male
Reported by a physician from Japan on 2012-02-20
Patient: 41 year old male
Reactions: Pancreatitis Acute, Death, Hyperlipidaemia, Hyperlactacidaemia, Amylase Increased, Neuropathy Peripheral, Diarrhoea, Lactic Acidosis, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Zerit
Dosage: ongoing 01-aug-1995 to 01-mar-1996 and 01-apr-1998 to 08-dec-2000.
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1995-08-01
End date: 2000-12-08
Videx
Dosage: ongoing 01/sept/1993 - 01/aug/1994; 01/mar/1996 - 01/oct/1996; and 10/jan/2000 - 08/dec/2000
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1993-09-01
End date: 2000-12-08
Efavirenz
Dosage: therapy interp 12/8/00,restarted 3/9/01,interrupt7/01,+restarted 7/23/01-25sep8(2622 days)
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2000-01-10
End date: 2008-09-25
Ziagen
Dosage: therapy interrupted from 08-dec-2000 to 05-jun-2001
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2000-01-24
End date: 2001-07-06
Somatropin Rdna
Indication: Weight Decreased
Start date: 2001-03-19
End date: 2001-11-12
Norvir
Dosage: 05jan01 to 04feb01, 05feb01 to 08mar01 and 26sep08 to ongoing.
Indication: HIV Infection
Start date: 2001-01-05
Kaletra
Dosage: 8 caps 9mar-6jul01, restarted 23jul01 stopped 4oct6 reduced to 6 tabs from 05oct6-15sep8 (1900 days)
Indication: HIV Infection
Start date: 2001-03-09
End date: 2008-09-25
Fosamprenavir Calcium
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-04
Prezista
Dosage: tabs
Administration route: Oral
Indication: HIV Infection
Start date: 2008-09-26
Raltegravir
Indication: Acquired Immunodeficiency Syndrome
Start date: 2008-09-26
Amprenavir
Administration route: Oral
Indication: HIV Infection
Start date: 2001-07-23
End date: 2005-08-03
Combivir
Administration route: Oral
Indication: HIV Infection
Start date: 2001-02-13
End date: 2001-05-10
Epivir
Dosage: therapy interrupted on 09-jan-2000, discontinued on 06-jul-2001.
Administration route: Oral
Start date: 1996-10-01
End date: 2001-07-06
Truvada
Dosage: 1 df = 1 tablet
Administration route: Oral
Indication: HIV Infection
Start date: 2008-09-26
End date: 2009-10-01
Saquinavir Mesylate
Indication: HIV Infection
Start date: 2001-01-05
End date: 2001-03-08
Other drugs received by patient: OIF; Loperamide HCL; Retrovir; Crixivan; Viracept; Recombinate; Loperamide HCL
|